SAN DIEGO, CA--(Marketwire - April 29, 2009) -
Accelrys, Inc. (NASDAQ:
ACCL), a leading
provider of scientific business intelligence software and services, today
announced that Dr. Frank Brown, Chief Science Officer of Accelrys, will be
presenting at the Nanotech Conference being held at the George R. Brown
Convention Center in Houston, Texas, from May 3 to May 7, 2009. In a
session titled "Scientific Business Intelligence for Nanotechnology"
scheduled for Monday, May 4 at 1:30 p.m., Dr. Brown will address the
challenges in integrating data and applications to help scientists and
engineers make more informed decisions. He will also address how to use the
same systems to better collaborate and share information across the
enterprise.
Nanotech 2009 is the largest international nanotechnology conference and
trade show in the world. The conference brings together specialists from a
wide range of fields of science, technology and business. For more
information on the conference, visit http://www.nsti.org/Nanotech2009/
About Accelrys, Inc.
Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and
solutions for the life sciences, energy, chemicals, aerospace, and consumer
products industries. Customers include many
Fortune 500 companies and other commercial entities, as well as academic
and government entities. Accelrys has a vast portfolio of computer-aided
design modeling and simulation offerings which assist customers in
conducting scientific experiments 'in silico' in order to reduce the
duration and cost of discovering and developing new drugs and materials.
Its scientific business
intelligence platform underlies the company's computer-aided design
modeling and simulation offerings. The Accelrys platform can be used with
both Accelrys and competitive products, as well as with customers'
proprietary predictive science products. Its flexibility, ease-of-use and
advanced chemical, text and image analysis and reporting capabilities
enable customers to mine, aggregate, analyze and report scientific data
from disparate sources, thereby better utilizing scientific data within
their organizations. For more information about Accelrys, visit
http://accelrys.com/
Forward-Looking Statements
This press release contains forward-looking statements. Such statements,
including statements relating to the Company's products, their features,
and their impact upon our customers' organizations, are subject to risks
and uncertainties including, but not limited to, the risk that our products
will not be successfully developed, achieve market acceptance, have the
anticipated impact upon our customers' organizations, and other risks and
uncertainties described in documents Accelrys has filed with the Securities
and Exchange Commission, including its most recent report on Form 10-K and
any subsequent interim filings. All forward-looking statements in this
document are qualified entirely by the cautionary statements included in
this document and such filings. These risks and uncertainties could cause
actual results to differ materially from results expressed or implied by
forward-looking statements contained in this document. These
forward-looking statements speak only as of the date of this document.
Accelrys disclaims any intent or obligation to publicly update or revise
any
forward-looking statements contained herein to reflect any change in its
expectations with regard thereto or any change in events, conditions or
circumstances on which any such statement is based.
